Microbial Metabolism of Yangonin, a Styryl Lactone from Piper methysticum (Kava)

다국어 초록 (Multilingual Abstract)

Microbial metabolism studies of yangonin (1), a major styryl lactone from Piper methysticum, have resulted in the production of three hydroxylated metabolites (2-4). The chemical structures of these compounds were elucidated to be 4-methoxy-6-(12-hydroxystyryl)-2-pyrone (2), 4-methoxy-6-(11,12-dihydroxystyryl)-2-pyrone (3), and 4,12-dimethoxy-6-(7,8-dihydroxy-7,8-dihydrostyryl)-2-pyrone (4) on the basis of the chemical and spectroscopic analyses. The compounds 3 and 4 are reported herein as microbial metabolites of yangonin for the first time.

참고문헌 (Reference)

1 Singh, Y.N, "Therapeutic potential of kava in the treatment of anxiety disorders" 16 : 731-743, 2002

2 Clark, A.M, "The use of microorganisms for the study of drug metabolism" 5 : 231-253, 1985

3 Shao, Y., "Reversed-phase highperformance liquid chromatographic method for quantitative analysis of the six major kavalactones in Piper methysticum" 825 : 1-8, 1998

4 Abourashed, E.A, "Microbial transformation of kawain and methysticin" 48 : 1996-1998, 2000

5 Herath, W, "Microbial metabolism. Part 5. Dihydrokawain" 52 : 1372-1374, 2004

6 Rasmussen, A.K, "Metabolism of some kava pyrones in the rat" 9 : 1-16, 1979

7 Matsuda, H, "Melanogenesis stimulation in murine B16 melanoma cells by kava (Piper methysticum) rhizome extract and kavalactones" 29 : 834-837, 2006

8 Tarbah, F, "Kinetics of kavain and its metabolites after oral application" 789 : 115-130, 2003

9 Dharmaratne, H.R.W, "Kavalactones from Piper methysticum, and their 13C NMR spectroscopic analyses" 59 : 429-433, 2002

10 Singh, Y.N, "Kava: An Overview. Distribution, mythology, botany, culture, chemistry, and pharmacology of the South Pacific's most revered herb" 39 : 33-55, 1997

11 Volz, H.P, "Kava-kava extract WS 1490 versus placebo in anxiety disorders- a randomized placebo-controlled 25-week outpatient trial" 30 : 1-5, 1997

12 Bilia, A.G, "Kava-kava and anxiety: Growing knowledge about the efficacy and safety" 70 : 2581-2597, 2002

13 Whitton, P.A, "Kava lactones and the kava-kava controversy" 64 : 673-679, 2003

14 Hashimoto, T, "Isolation and synthesis of TNF-α release inhibitors from Fijian kawa (Piper methysticum)" 10 : 309-317, 2003

15 Duffield, A.M, "Identification of some human urinary metabolites of the intoxicating beverage kava" 475 : 273-281, 1989

16 Johnson, B.M, "Identification of novel electrophilic metabolites of Piper methysticum Forst (Kava)" 16 : 733-740, 2003

17 Edwards, R.L, "Constituents of the higher fungi. Part VI. Some analogs of hispidin" 6 : 411-413, 1967

18 Edwards, R.L, "Constituents of the higher fungi. Part I. Hispidin, a new 4-hydroxy-6-styryl-2-pyrone from Polyporus hispidus" 4995-5002, 1961

19 Venisetty, R.K, "Application of microbial biotransformation for the new drug discovery using natural drugs as substrates" 4 : 153-167, 2003

20 Adam, W, "A convenient synthesis of hispidin from piperonal" 11 : 1133-1134, 1994

21 Dong, H, "A New Antiplatelet Diarylheptanoid from Alpinia blepharocalyx" 61 : 142-144, 1998